The FDA has approved an ingestible event marker from the privately-held digital health company etectRx, as its rival “digital pill” company Proteus faces financial difficulties. Florida-based ...
In its second attempt, Takeda has secured FDA approval for Eohilia ... antibody Dupixent (dupilumab), which was approved for the condition in 2022. Faced with the cost of a second trial, the ...
The FDA has granted approval to revumenib for the treatment of adult and pediatric patients with relapsed/refractory KMT2A-rearranged acute leukemia. 1 Data from the phase 1/2 AUGMENT-101 trial, as ...
Eladocagene exuparvovec is the first US-approved gene therapy for AADC deficiency, administered directly to the brain. Clinical trials showed significant motor and cognitive improvements ...
An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and state employees implement a diabetes management program that includes mental ...
Califf is the commissioner of the Food and Drug Administration. Warraich is the senior clinical adviser for chronic disease to the FDA commissioner ... must put tackling diet-related disease ...